Kynurenines and the Endocannabinoid System in Schizophrenia: Common Points and Potential Interactions
Open Access
Abstract
Schizophrenia, which affects around 1% of the world’s population, has been described as a complex set of symptoms triggered by multiple factors. However, the exact background mechanisms remain to be explored, whereas therapeutic agents with excellent effectivity and safety profiles have yet to be developed. Kynurenines and the endocannabinoid system (ECS) play significant roles in both the development and manifestation of schizophrenia, which have been extensively studied and reviewed previously. Accordingly, kynurenines and the ECS share multiple features and mechanisms in schizophrenia, which have yet to be reviewed. Thus, the present study focuses on the main common points and potential interactions between kynurenines and the ECS in schizophrenia, which include (i) the regulation of glutamatergic/dopaminergic/γ-aminobutyric acidergic neurotransmission, (ii) their presence in astrocytes, and (iii) their role in inflammatory mechanisms. Additionally, promising pharmaceutical approaches involving the kynurenine pathway and the ECS will be reviewed herein.Keywords
Funding Information
- GINOP by the Ministry of Human Capacities (2.3.2-15-2016-00034)
- Hungary grant 20391-3/2018 FEKUSTRAT (20391-3/2018)
- the grant of National Research, Development and Innovation Office (K124952)
- University of Szeged Open Access Fund (Grant number: 4301)
This publication has 338 references indexed in Scilit:
- Childhood infection and adult schizophrenia: A meta-analysis of population-based studiesSchizophrenia Research, 2012
- Functional α7 Nicotinic ACh Receptors on Astrocytes in Rat Hippocampal CA1 SlicesJournal of Molecular Neuroscience, 2012
- Rimonabant for neurocognition in schizophrenia: A 16-week double blind randomized placebo controlled trialSchizophrenia Research, 2012
- Cortical parvalbumin interneurons and cognitive dysfunction in schizophreniaTrends in Neurosciences, 2012
- Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantaminePsychopharmacology, 2011
- Molecular signals of plasticity at the tetrapartite synapseCurrent Opinion in Neurobiology, 2011
- Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistryNeuroscience, 2010
- Cannabinoid and cannabinoid‐like receptors in microglia, astrocytes, and astrocytomasGlia, 2010
- Structure, expression, and function of kynurenine aminotransferases in human and rodent brainsCellular and Molecular Life Sciences, 2009
- Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatumNeuroscience, 2009